Verve Therapeutics, Inc.

Q4 2023 13F Holders

Symbol: VERV
CUSIP: 92539P101
Type: Equity
Class: COM
Num filings: 169
Total reported value, excl. options: $1.08 B

Compare 2023 Q4 to

Manager	Report Date	Value ($000)	Shares	Option Type